As of December 31, 2023, Alpine’s cash and investments totaled $368.2 million compared to $273.4 million as of December 31, 2022. The Company anticipates its current cash and investments are sufficient to fund planned operations into 2026.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALPN:
- Options Volatility and Implied Earnings Moves Today, March 18, 2024
- Alpine Immune Sciences (ALPN) Q4 Earnings Cheat Sheet
- Alpine Immune Sciences price target raised to $41 from $29 at RBC Capital
- Alpine Immune Sciences assumed with an Outperform at Oppenheimer
- Wolfe starts Alpine at Outperform, says bullish on de-risked mechanism
